Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05808946

Alpha-Lipoic Acid in Patients With Sepsis

The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis

Sponsor: Ain Shams University

Conditions Sepsis

Interventions Alpha-Lipoic Acid Sepsis Supportive Care

Updated 4 times since 2023 Last updated: Mar 30, 2023 Started: Mar 10, 2023 Primary completion: Oct 31, 2024 Completion: Oct 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Sepsis, this trial is ongoing. The trial is conducted by Ain Shams University and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Unknown PHASE2/PHASE3

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
May 2023 — Jul 2024 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt